2nd Quarter - Termination

POLICY IMPACT COMMUNICATIONS, INC. for MILLENNIUM: THE TAKEDA ONCOLOGY COMPANY

Firm
Client
Income
$20,000
Expenses
—
Terminated
May 31, 2010

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1427-Promoting Innovation and Access to Life-Saving Medicine Act H.R. 1548-Pathway for Biosimilars Act S. 726-Promoting Innovation Access to Life-Saving Medicine Act The Affordable Health Choices Act America's Healthy Future Act of 2009

LobbyistCovered position, as disclosed
JOHN M HADDOW Legislative Assistant
JOHN DREW HIATT Staff Director for the Small Business Committee
WILLIAM NIXON Senior Policy Advisor/Communications Director
MATTHEW SALMON U.S. Representative from Arizona's 1st District

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1548 (111th), S. 726 (111th), H.R. 1427 (111th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.